Support Designed Around You
Support Designed Around You
Kalvista Cares offers a range of programs and resources to help support patients and caregivers. Our Care Managers can help connect you to programs designed to support your treatment experience.
Financial & Access Assistance

-
Copay Support: The KalVista Cares Co-Pay Assistance Program may help you save on EKTERLY® (sebetralstat) and reduce out-of-pocket costs. With the KalVista Cares Co-Pay Assistance Program, eligible commercially insured patients may pay as little as $0 for their EKTERLY prescription.*
-
Additional Assistance Options: Other forms of support may be available depending on your situation. A Care Manager can help explain which options may be right for you and help you save on treatment costs based on your eligibility.
Your Care Manager will review your insurance coverage with you and determine if you are eligible for the KalVista Cares Co-Pay Assistance Program.*
*IMPORTANT NOTICE: This co-pay assistance program is intended only for eligible patients with commercial (private) insurance. Patients with government-funded insurance, such as Medicare, Medicaid, TRICARE, or any state or federal health insurance program, are not eligible to participate. Participation in the program is subject to eligibility requirements and program limits. The program may cover a portion or all of the patient’s out-of-pocket costs up to a maximum amount determined by the program. Terms and conditions may change from time to time, or the program may be discontinued at any time without notice. By participating, patients agree to comply with all terms and conditions.
Patient Resources
Access tools and resources designed to help you better understand your care and treatment.
Advocacy Groups
Resources for Parents & Caregivers
INDICATION AND IMPORTANT SAFETY INFORMATION
WHAT IS EKTERLY® (sebetralstat)?
EKTERLY is a prescription medicine used to treat sudden (acute) attacks of hereditary angioedema (HAE) in adults and children aged 12 years of age and older. It is not known if EKTERLY is safe and effective in children under 12 years of age.
IMPORTANT SAFETY INFORMATION
Before taking EKTERLY, tell your healthcare provider about all of your medical conditions, including if you:
- Are pregnant or planning to become pregnant. It is not known if EKTERLY can harm your unborn baby.
- Are breastfeeding or plan to breastfeed. It is not known if EKTERLY passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby while taking EKTERLY.
- Have liver problems.
Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking EKTERLY with certain other medicines can cause side effects or affect how well EKTERLY or the other medicines work. Especially tell your healthcare provider if you take any of the following, as their use with EKTERLY is not recommended: itraconazole, phenytoin, efavirenz.
Know the medicines you take. Keep a list of them to show your healthcare provider or pharmacist when you get a new medicine.
What are the possible side effects of EKTERLY?
The most common side effects of EKTERLY include headache. For more information, ask your healthcare provider or pharmacist. Talk to your doctor for medical advice about side effects.
You are encouraged to report side effects related to KalVista products by calling 1-855-258-4782. If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see full Prescribing Information, including Patient Information.





